NanoGroup S.A.’s acquisition of bridge financing.
The Management Board of NanoGroup S.A. has received offers from investors interested in acquiring series L shares issued (on the basis of the resolution of
2024-03-25
The Management Board of NanoGroup S.A. has received offers from investors interested in acquiring series L shares issued (on the basis of the resolution of
In addition to the kidneys and liver, the innovative NanOx system also works well in heart perfusion, as proven by a recent study conducted in
The conducted pig liver perfusion is another step taken by the company to introduce an innovative organ perfusion system to the Polish market. NanoGroup’s first
Today on Fakty TVN, Prof. Dr. Katherine H. K., a professor of transplantation, spoke about our research, the record time for keeping a kidney out
Prof. NanoGroup S.A. talks about the future of transplantation, the possibilities that the technology being developed by NanoGroup S.A. opens up for the field, and
“The problem of transplantation – at least in the case of the kidney – is that there is still no definitively established one or more
We are pleased to announce that Przemyslaw Mazurek has joined NanoGroup to take on the role of CEO. He knows the Company quite well from
We are extremely pleased to announce that NanoGroup S.A. Board Member Prof. Tomasz Ciach was included in the list of 30 entrepreneurs from Warsaw worth
Today is World Intellectual Property Day. As patent holders in many global markets, this is a special celebration for us. We believe that innovation, essential